Marzetti (MZTI) Financials

$114.01 -0.38 (-0.33%)

Closing price 05/15/2026 04:00 PM Eastern

Extended Trading

$114.06 +0.05 (+0.04%)

As of 05/15/2026 04:10 PM Eastern

Annual Income Statements for Marzetti

This table shows Marzetti's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025
Net Income / (Loss) Attributable to Common Shareholders	102	122	115	135	151	137	142	90	111	159	167
Consolidated Net Income / (Loss)	102	122	115	135	151	137	142	90	111	159	167
Net Income / (Loss) Continuing Operations	102	122	115	135	151	137	142	90	111	159	167
Total Pre-Tax Income	155	185	176	174	196	179	186	112	143	206	213
Total Operating Income	155	185	174	172	191	176	186	112	142	199	220
Total Gross Profit	258	300	319	304	326	358	387	356	389	432	456
Total Revenue	1,105	1,191	1,202	1,223	1,308	1,334	1,467	1,676	1,823	1,872	1,909
Operating Revenue	1,105	1,191	1,202	1,223	1,308	1,334	1,467	1,676	1,823	1,872	1,909
Total Cost of Revenue	847	891	883	919	982	976	1,080	1,321	1,434	1,439	1,453
Operating Cost of Revenue	847	891	883	919	982	976	1,080	1,321	1,434	1,439	1,453
Total Operating Expenses	103	115	144	132	135	182	201	244	247	233	249
Selling, General & Admin Expense	103	115	126	130	150	181	205	212	222	218	230
Restructuring Charge	-	-	0.00	0.00	1.64	0.89	1.20	35	25	15	5.10
Other Special Charges / (Income)	0.00	0.00	19	2.05	-16	0.26	-5.69	-3.47	0.00	0.00	14
Total Other Income / (Expense), net	-0.31	0.06	1.16	2.66	4.62	3.13	-0.11	0.48	1.79	6.15	7.11
Other Income / (Expense), net	-0.31	0.06	1.16	2.66	4.62	3.13	-0.11	0.48	1.79	6.15	7.11
Income Tax Expense	53	63	60	39	45	42	43	23	32	47	46
Basic Earnings per Share	$3.72	$4.45	$4.21	$4.93	$5.48	$4.98	$5.17	$3.26	$4.04	$5.77	$6.08
Weighted Average Basic Shares Outstanding	27.30M	27.34M	27.38M	27.40M	27.44M	27.45M	27.48M	27.45M	27.46M	27.44M	27.47M
Diluted Earnings per Share	$3.72	$4.44	$4.20	$4.92	$5.46	$4.97	$5.16	$3.25	$4.04	$5.76	$6.07
Weighted Average Diluted Shares Outstanding	27.33M	27.37M	27.44M	27.46M	27.54M	27.50M	27.52M	27.47M	27.48M	27.46M	27.49M
Weighted Average Basic & Diluted Shares Outstanding	27.30M	27.40M	27.40M	27.40M	27.49M	27.52M	27.53M	27.52M	27.53M	27.53M	27.53M
Cash Dividends to Common per Share	$1.82	$6.96	$2.15	$2.35	$2.55	$2.75	$2.95	$3.15	$3.35	$3.55	$3.75

This table shows Marzetti's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	44	51	28	35	45	49	41	33	47	59	37
Consolidated Net Income / (Loss)	44	51	28	35	45	49	41	33	47	59	37
Net Income / (Loss) Continuing Operations	44	51	28	35	45	49	41	33	47	59	37
Total Pre-Tax Income	58	67	37	44	58	63	52	41	61	76	48
Total Operating Income	57	66	35	42	56	76	50	39	59	75	47
Total Gross Profit	109	121	104	98	111	133	106	106	119	137	107
Total Revenue	462	486	471	453	467	509	458	475	493	518	453
Operating Revenue	462	486	471	453	467	509	458	475	493	518	453
Total Cost of Revenue	353	364	367	355	356	377	352	369	375	381	346
Operating Cost of Revenue	353	364	367	355	356	377	352	369	375	381	346
Total Operating Expenses	52	56	69	56	55	71	56	81	60	62	61
Selling, General & Admin Expense	52	56	57	53	55	57	56	62	58	60	61
Restructuring Charge	-	-	12	-	0.00	0.00	0.00	-	1.14	1.67	-0.80
Other Special Charges / (Income)	-	0.00	0.00	-	-	14	0.00	-	-	0.00	0.00
Total Other Income / (Expense), net	0.86	1.43	1.75	2.12	2.02	1.54	1.96	16	1.53	1.16	1.74
Other Income / (Expense), net	0.86	1.43	1.75	2.12	2.02	1.54	1.96	16	1.53	1.16	1.74
Income Tax Expense	14	16	8.54	8.98	13	14	11	7.98	14	17	11
Basic Earnings per Share	$1.60	$1.87	$1.03	$1.27	$1.62	$1.78	$1.49	$1.19	$1.71	$2.15	$1.35
Weighted Average Basic Shares Outstanding	27.45M	27.43M	27.44M	27.44M	27.46M	27.48M	27.48M	27.47M	27.46M	27.40M	27.36M
Diluted Earnings per Share	$1.59	$1.87	$1.03	$1.27	$1.62	$1.78	$1.49	$1.18	$1.71	$2.15	$1.35
Weighted Average Diluted Shares Outstanding	27.47M	27.44M	27.45M	27.46M	27.48M	27.50M	27.50M	27.49M	27.49M	27.42M	27.38M
Weighted Average Basic & Diluted Shares Outstanding	27.52M	27.52M	27.53M	27.53M	27.57M	27.57M	27.57M	27.53M	27.49M	27.42M	27.42M
Cash Dividends to Common per Share	$0.85	$0.90	$0.90	$0.90	$0.90	$0.95	$0.95	-	$0.95	$1.00	$1.00

This table details how cash moves in and out of Marzetti's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025
Net Change in Cash & Equivalents	-29	-64	25	63	-9.46	1.99	-10	-128	28	75	-1.97
Net Cash From Operating Activities	133	146	146	161	198	171	174	102	226	252	261
Net Cash From Continuing Operating Activities	133	146	146	161	198	171	174	102	226	252	261
Net Income / (Loss) Continuing Operations	102	122	115	135	151	137	142	90	111	159	167
Consolidated Net Income / (Loss)	102	122	115	135	151	137	142	90	111	159	167
Depreciation Expense	21	24	25	27	32	38	45	46	51	56	62
Non-Cash Adjustments To Reconcile Net Income	1.89	3.03	3.38	4.60	6.85	5.58	8.23	41	34	25	28
Changes in Operating Assets and Liabilities, net	8.09	-3.04	2.79	-6.09	8.35	-9.76	-21	-75	30	12	3.65
Net Cash From Investing Activities	-112	-17	-61	-31	-127	-83	-89	-132	-91	-67	-148
Net Cash From Continuing Investing Activities	-112	-17	-61	-31	-127	-83	-89	-132	-91	-67	-148
Purchase of Property, Plant & Equipment	-18	-17	-27	-31	-71	-83	-88	-132	-90	-68	-58
Acquisitions	-92	-0.01	-35	-0.32	-55	-	-	-	0.00	0.00	-79
Sale of Property, Plant & Equipment	0.00	0.00	1.48	0.04	0.17	0.13	0.15	0.37	1.21	6.97	0.00
Other Investing Activities, net	-1.81	-0.74	0.09	-0.15	-0.79	-0.75	-1.26	-0.64	-1.81	-6.83	-11
Net Cash From Financing Activities	-50	-193	-61	-67	-80	-86	-95	-97	-107	-109	-115
Net Cash From Continuing Financing Activities	-50	-193	-61	-67	-80	-86	-95	-97	-107	-109	-115
Repurchase of Common Equity	-0.57	-0.16	-0.87	-1.10	-7.41	-5.46	-8.53	-7.56	-9.20	-7.65	-7.99
Payment of Dividends	-50	-191	-59	-65	-70	-76	-81	-87	-92	-98	-104
Other Financing Activities, net	0.56	-1.90	-0.91	-0.98	-2.36	-3.81	-5.66	-3.02	-5.36	-3.57	-3.76

This table details how cash moves in and out of Marzetti's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	-15	60	31	-1.31	-28	68	-79	37	21	19	17
Net Cash From Operating Activities	36	106	76	34	20	108	46	88	70	89	71
Net Cash From Continuing Operating Activities	36	106	76	34	20	108	46	88	70	89	71
Net Income / (Loss) Continuing Operations	44	51	28	35	45	49	41	33	47	59	37
Consolidated Net Income / (Loss)	44	51	28	35	45	49	41	33	47	59	37
Depreciation Expense	14	14	14	14	14	15	16	17	17	18	18
Non-Cash Adjustments To Reconcile Net Income	2.51	3.01	16	4.10	2.51	17	1.56	7.61	3.79	2.89	2.43
Changes in Operating Assets and Liabilities, net	-24	37	17	-19	-42	27	-13	31	1.83	9.12	14
Net Cash From Investing Activities	-20	-20	-17	-10	-20	-13	-98	-18	-19	-21	-25
Net Cash From Continuing Investing Activities	-20	-20	-17	-10	-20	-13	-98	-18	-19	-21	-25
Purchase of Property, Plant & Equipment	-18	-19	-15	-16	-18	-11	-15	-14	-16	-18	-21
Other Investing Activities, net	-1.41	-1.67	-2.32	-1.43	-2.28	-1.76	-3.68	-3.67	-3.19	-4.03	-3.43
Net Cash From Financing Activities	-31	-25	-28	-25	-28	-27	-27	-33	-30	-48	-29
Net Cash From Continuing Financing Activities	-31	-25	-28	-25	-28	-27	-27	-33	-30	-48	-29
Repurchase of Common Equity	-6.65	-0.04	-0.93	-0.02	-1.44	-0.00	-0.08	-6.47	-1.14	-20	-0.02
Payment of Dividends	-23	-25	-25	-25	-25	-26	-26	-26	-26	-28	-27
Other Financing Activities, net	-0.50	-0.48	-2.09	-0.49	-2.06	-0.55	-0.51	-0.64	-2.57	-0.54	-0.55
Cash Income Taxes Paid	6.23	8.05	15	-	16	5.32	21	-	13	0.80	11

This table presents Marzetti's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025
Total Assets	702	635	716	804	905	993	1,101	1,090	1,113	1,207	1,275
Total Current Assets	330	268	301	379	369	386	423	352	374	444	444
Cash & Equivalents	182	118	143	206	196	198	188	60	88	163	161
Accounts Receivable	62	66	70	73	76	87	98	135	115	96	96
Inventories, net	78	76	76	91	86	85	122	145	158	173	169
Other Current Assets	7.67	7.64	12	9.30	11	16	16	11	13	12	17
Plant, Property, & Equipment, net	172	170	181	191	247	293	365	451	482	478	535
Plant, Property & Equipment, gross	367	380	397	426	503	575	676	786	854	878	968
Accumulated Depreciation	195	211	217	235	256	282	312	334	372	400	433
Total Noncurrent Assets	200	197	235	235	290	314	313	287	256	285	297
Goodwill	144	144	168	168	208	208	208	208	208	208	223
Other Noncurrent Operating Assets	8.08	8.66	6.40	11	11	41	46	47	43	77	74
Total Liabilities & Shareholders' Equity	702	635	716	804	905	993	1,101	1,090	1,113	1,207	1,275
Total Liabilities	121	121	140	152	179	210	258	246	251	281	276
Total Current Liabilities	75	73	77	94	120	126	174	166	169	184	186
Accounts Payable	39	40	41	58	77	71	110	115	112	119	118
Accrued Expenses	36	33	35	36	43	55	64	51	57	65	68
Total Noncurrent Liabilities	47	48	64	58	59	84	84	80	82	97	90
Noncurrent Deferred & Payable Income Tax Liabilities	23	21	25	17	23	34	39	39	47	37	34
Other Noncurrent Operating Liabilities	24	27	39	42	36	50	46	41	35	60	56
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	581	514	576	652	727	783	843	845	862	926	998
Total Preferred & Common Equity	581	514	576	652	727	783	843	845	862	926	998
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	581	514	576	652	727	783	843	845	862	926	998
Common Stock	108	111	115	119	123	125	129	138	144	154	161
Retained Earnings	1,219	1,150	1,207	1,279	1,360	1,421	1,482	1,485	1,504	1,565	1,628
Treasury Stock	-736	-736	-737	-738	-745	-751	-759	-767	-776	-784	-792
Accumulated Other Comprehensive Income / (Loss)	-10	-11	-8.94	-8.26	-10	-12	-8.25	-11	-9.37	-8.64	0.96

This table presents Marzetti's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	12/31/2022	3/31/2023	9/30/2023	12/31/2023	3/31/2024	9/30/2024	12/31/2024	3/31/2025	9/30/2025	12/31/2025	3/31/2026
Total Assets	1,137	1,158	1,130	1,149	1,172	1,216	1,240	1,277	1,338	1,329	1,356
Total Current Assets	374	392	386	405	441	453	481	440	499	491	514
Cash & Equivalents	95	83	74	134	165	135	203	125	182	202	218
Accounts Receivable	127	131	120	100	103	102	99	107	102	104	98
Inventories, net	139	155	178	158	161	194	167	191	174	163	175
Other Current Assets	12	23	15	13	12	22	12	17	41	23	22
Plant, Property, & Equipment, net	481	485	489	490	484	480	479	538	542	541	546
Plant, Property & Equipment, gross	834	847	871	880	874	893	897	970	991	993	1,011
Accumulated Depreciation	353	362	382	389	390	413	418	432	449	452	465
Total Noncurrent Assets	282	281	255	253	248	283	280	299	297	297	296
Goodwill	208	208	208	208	208	208	208	223	223	223	223
Other Noncurrent Operating Assets	43	42	42	40	39	75	72	76	75	74	73
Total Liabilities & Shareholders' Equity	1,137	1,158	1,130	1,149	1,172	1,216	1,240	1,277	1,338	1,329	1,356
Total Liabilities	258	285	252	241	259	271	260	280	320	296	311
Total Current Liabilities	180	196	167	163	190	173	167	186	201	181	199
Accounts Payable	132	138	120	104	121	109	105	121	135	123	135
Accrued Expenses	48	58	47	59	69	64	63	65	66	57	64
Total Noncurrent Liabilities	77	88	84	77	69	98	93	94	118	115	112
Noncurrent Deferred & Payable Income Tax Liabilities	40	52	53	48	43	42	37	38	56	55	54
Other Noncurrent Operating Liabilities	37	36	32	29	27	56	55	56	62	60	58
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	880	873	879	908	913	945	980	996	1,019	1,033	1,045
Total Preferred & Common Equity	880	873	879	908	913	945	980	996	1,019	1,033	1,045
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	880	873	879	908	913	945	980	996	1,019	1,033	1,045
Common Stock	141	142	146	149	151	154	157	158	161	164	167
Retained Earnings	1,517	1,518	1,524	1,551	1,555	1,584	1,607	1,622	1,649	1,681	1,690
Treasury Stock	-767	-776	-783	-783	-784	-785	-785	-785	-793	-813	-813
Accumulated Other Comprehensive Income / (Loss)	-11	-11	-9.29	-9.21	-9.14	-8.57	1.01	0.96	0.95	0.93	0.92

This table displays calculated financial ratios and metrics derived from Marzetti's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	6.09%	7.84%	0.90%	1.75%	6.94%	2.03%	9.94%	14.27%	8.72%	2.70%	2.00%
EBITDA Growth	1.14%	18.85%	-4.00%	0.34%	13.07%	-4.55%	6.09%	-31.26%	22.90%	34.40%	10.78%
EBIT Growth	0.83%	19.46%	-4.94%	-0.75%	12.25%	-8.42%	3.72%	-39.49%	27.50%	43.42%	10.66%
NOPAT Growth	0.57%	19.47%	-5.89%	16.33%	10.31%	-8.44%	5.81%	-37.36%	23.19%	40.01%	12.25%
Net Income Growth	35.61%	19.75%	-5.30%	17.34%	11.26%	-9.01%	3.90%	-37.06%	24.22%	42.53%	5.51%
EPS Growth	35.77%	19.35%	-5.41%	17.14%	10.98%	-8.97%	3.82%	-37.02%	24.31%	42.57%	5.38%
Operating Cash Flow Growth	2.85%	9.89%	0.33%	9.79%	22.95%	-13.58%	2.00%	-41.55%	121.88%	11.36%	3.95%
Free Cash Flow Firm Growth	-75.77%	517.46%	-38.20%	54.92%	-47.37%	27.34%	-9.73%	-155.43%	400.47%	37.20%	-40.71%
Invested Capital Growth	25.75%	-0.80%	9.44%	3.16%	18.82%	10.26%	11.98%	19.74%	-1.35%	-1.48%	9.80%
Revenue Q/Q Growth	1.74%	0.57%	0.45%	1.52%	1.20%	-0.21%	4.61%	4.15%	0.12%	-0.10%	1.20%
EBITDA Q/Q Growth	4.71%	3.88%	-1.55%	0.65%	1.17%	-1.30%	0.99%	-4.48%	-8.65%	13.36%	4.99%
EBIT Q/Q Growth	4.42%	4.50%	-2.06%	0.49%	0.23%	-2.18%	0.33%	-5.82%	-13.04%	18.01%	4.92%
NOPAT Q/Q Growth	4.78%	4.23%	-2.21%	2.77%	0.49%	-1.46%	1.03%	-3.15%	-15.68%	19.15%	-1.07%
Net Income Q/Q Growth	4.35%	4.32%	-1.81%	2.97%	0.42%	-1.88%	0.95%	-2.91%	-15.16%	19.30%	-1.36%
EPS Q/Q Growth	69.86%	4.23%	-2.10%	3.14%	0.37%	-1.97%	0.78%	-2.40%	-15.13%	19.25%	-1.46%
Operating Cash Flow Q/Q Growth	4.66%	6.67%	-4.04%	3.01%	5.50%	-1.47%	-8.48%	8.15%	-0.62%	-2.95%	26.07%
Free Cash Flow Firm Q/Q Growth	212.84%	3.52%	-11.04%	0.88%	-1.96%	16.64%	-37.88%	32.53%	8.03%	-3.52%	92.19%
Invested Capital Q/Q Growth	-2.26%	-2.12%	-0.36%	0.22%	0.56%	-1.76%	5.66%	1.67%	-2.09%	1.90%	-3.98%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	23.33%	25.16%	26.52%	24.82%	24.94%	26.83%	26.36%	21.22%	21.32%	23.10%	23.87%
EBITDA Margin	15.90%	17.53%	16.68%	16.44%	17.39%	16.27%	15.69%	9.44%	10.67%	13.97%	15.17%
Operating Margin	14.02%	15.50%	14.51%	14.03%	14.60%	13.19%	12.67%	6.68%	7.76%	10.65%	11.54%
EBIT Margin	13.99%	15.50%	14.60%	14.24%	14.95%	13.42%	12.66%	6.70%	7.86%	10.98%	11.91%
Profit (Net Income) Margin	9.21%	10.22%	9.59%	11.06%	11.51%	10.27%	9.70%	5.34%	6.11%	8.47%	8.77%
Tax Burden Percent	65.79%	65.95%	65.70%	77.68%	76.99%	76.49%	76.63%	79.71%	77.66%	77.18%	78.40%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	93.86%
Effective Tax Rate	34.21%	34.05%	34.30%	22.32%	23.01%	23.51%	23.37%	20.29%	22.34%	22.82%	21.60%
Return on Invested Capital (ROIC)	28.47%	30.65%	27.66%	30.31%	30.09%	24.13%	22.97%	12.39%	14.11%	20.03%	21.60%
ROIC Less NNEP Spread (ROIC-NNEP)	28.57%	30.62%	27.07%	29.12%	28.32%	22.92%	23.01%	12.09%	12.24%	16.26%	24.91%
Return on Net Nonoperating Assets (RNNOA)	-10.14%	-8.40%	-6.49%	-8.27%	-8.26%	-5.99%	-5.47%	-1.78%	-1.07%	-2.29%	-4.21%
Return on Equity (ROE)	18.33%	22.25%	21.17%	22.03%	21.83%	18.14%	17.50%	10.62%	13.04%	17.74%	17.39%
Cash Return on Invested Capital (CROIC)	5.65%	31.46%	18.64%	27.20%	12.88%	14.37%	11.67%	-5.57%	15.47%	21.53%	12.26%
Operating Return on Assets (OROA)	23.05%	27.62%	25.98%	22.91%	22.87%	18.86%	17.74%	10.26%	13.01%	17.72%	18.33%
Return on Assets (ROA)	15.17%	18.22%	17.07%	17.79%	17.61%	14.43%	13.59%	8.18%	10.10%	13.67%	13.49%
Return on Common Equity (ROCE)	18.33%	22.25%	21.17%	22.03%	21.83%	18.14%	17.50%	10.62%	13.04%	17.74%	17.39%
Return on Equity Simple (ROE_SIMPLE)	17.50%	23.71%	20.02%	20.74%	20.71%	17.49%	16.88%	10.61%	12.91%	17.13%	0.00%
Net Operating Profit after Tax (NOPAT)	102	122	115	133	147	135	142	89	110	154	173
NOPAT Margin	9.22%	10.22%	9.53%	10.90%	11.24%	10.09%	9.71%	5.32%	6.03%	8.22%	9.05%
Net Nonoperating Expense Percent (NNEP)	-0.10%	0.03%	0.58%	1.18%	1.77%	1.21%	-0.04%	0.31%	1.87%	3.77%	-3.31%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	-	-	17.30%
Cost of Revenue to Revenue	76.67%	74.84%	73.48%	75.18%	75.06%	73.17%	73.64%	78.78%	78.68%	76.90%	76.13%
SG&A Expenses to Revenue	9.31%	9.66%	10.45%	10.62%	11.46%	13.56%	14.00%	12.65%	12.19%	11.65%	12.06%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	9.31%	9.66%	12.02%	10.79%	10.34%	13.65%	13.69%	14.54%	13.56%	12.44%	13.06%
Earnings before Interest and Taxes (EBIT)	155	185	176	174	196	179	186	112	143	206	227
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	176	209	200	201	227	217	230	158	195	261	290
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.49	5.90	5.14	5.23	5.13	5.05	5.96	4.04	6.29	5.62	4.77
Price to Tangible Book Value (P/TBV)	5.20	9.32	8.52	7.97	8.31	7.76	8.73	5.65	8.36	7.25	6.14
Price to Revenue (P/Rev)	1.83	2.54	2.47	2.79	2.85	2.97	3.43	2.04	2.98	2.78	2.49
Price to Earnings (P/E)	19.91	24.88	25.69	25.21	24.75	28.89	35.32	38.11	48.75	32.80	28.46
Dividend Yield	2.46%	5.84%	1.99%	1.89%	1.88%	1.91%	1.62%	2.54%	1.70%	1.88%	2.17%
Earnings Yield	5.02%	4.02%	3.89%	3.97%	4.04%	3.46%	2.83%	2.62%	2.05%	3.05%	3.51%
Enterprise Value to Invested Capital (EV/IC)	4.62	7.36	6.51	7.18	6.65	6.42	7.39	4.28	6.90	6.61	5.50
Enterprise Value to Revenue (EV/Rev)	1.67	2.44	2.35	2.62	2.70	2.82	3.30	2.00	2.93	2.69	2.41
Enterprise Value to EBITDA (EV/EBITDA)	10.49	13.95	14.07	15.94	15.52	17.32	21.02	21.19	27.44	19.27	15.89
Enterprise Value to EBIT (EV/EBIT)	11.92	15.77	16.06	18.40	18.05	20.99	26.05	29.84	37.25	24.52	20.23
Enterprise Value to NOPAT (EV/NOPAT)	18.08	23.92	24.61	24.06	24.01	27.93	33.98	37.60	48.57	32.75	26.64
Enterprise Value to Operating Cash Flow (EV/OCF)	13.88	19.96	19.26	19.95	17.86	22.01	27.78	32.94	23.63	20.03	17.60
Enterprise Value to Free Cash Flow (EV/FCFF)	91.07	23.31	36.53	26.81	56.08	46.90	66.89	0.00	44.29	30.47	46.94
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.35	-0.27	-0.24	-0.28	-0.29	-0.26	-0.24	-0.15	-0.09	-0.14	-0.17
Leverage Ratio	1.21	1.22	1.24	1.24	1.24	1.26	1.29	1.30	1.29	1.30	1.29
Compound Leverage Factor	1.21	1.22	1.24	1.24	1.24	1.26	1.29	1.30	1.29	1.30	1.21
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	15.19	20.75	17.88	18.34	17.11	15.56	15.73	12.33	17.16	15.29	14.46
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	4.42	3.67	3.93	4.04	3.08	3.05	2.43	2.12	2.22	2.41	2.38
Quick Ratio	3.28	2.52	2.78	2.97	2.27	2.26	1.64	1.18	1.21	1.41	1.38
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	20	125	77	120	63	80	72	-40	121	165	98
Operating Cash Flow to CapEx	725.61%	875.19%	573.38%	518.65%	279.44%	206.96%	198.59%	77.36%	253.91%	415.06%	450.86%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.65	1.78	1.78	1.61	1.53	1.41	1.40	1.53	1.65	1.61	1.54
Accounts Receivable Turnover	18.37	18.55	17.68	17.12	17.60	16.44	15.90	14.37	14.55	17.78	19.95
Inventory Turnover	11.11	11.58	11.58	11.00	11.10	11.41	10.44	9.91	9.47	8.68	8.49
Fixed Asset Turnover	6.48	6.97	6.86	6.58	5.97	4.94	4.46	4.11	3.90	3.90	3.77
Accounts Payable Turnover	22.07	22.64	21.73	18.51	14.58	13.18	11.89	11.72	12.65	12.49	12.28
Days Sales Outstanding (DSO)	19.87	19.68	20.64	21.32	20.74	22.20	22.95	25.41	25.08	20.53	18.29
Days Inventory Outstanding (DIO)	32.85	31.53	31.51	33.20	32.90	31.99	34.96	36.84	38.56	42.03	43.01
Days Payable Outstanding (DPO)	16.54	16.12	16.80	19.72	25.03	27.68	30.71	31.14	28.86	29.23	29.73
Cash Conversion Cycle (CCC)	36.18	35.08	35.35	34.80	28.61	26.50	27.20	31.11	34.78	33.33	31.58
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	399	396	433	447	531	585	655	784	774	762	837
Invested Capital Turnover	3.09	3.00	2.90	2.78	2.68	2.39	2.37	2.33	2.34	2.44	2.39
Increase / (Decrease) in Invested Capital	82	-3.20	37	14	84	54	70	129	-11	-11	75
Enterprise Value (EV)	1,842	2,912	2,820	3,206	3,530	3,759	4,839	3,354	5,337	5,038	4,602
Market Capitalization	2,025	3,030	2,963	3,412	3,726	3,957	5,027	3,414	5,426	5,202	4,763
Book Value per Share	$21.23	$18.74	$20.99	$23.74	$26.43	$28.47	$30.61	$30.69	$31.33	$33.63	$36.22
Tangible Book Value per Share	$14.23	$11.86	$12.67	$15.58	$16.30	$18.52	$20.91	$21.95	$23.58	$26.06	$28.14
Total Capital	581	514	576	652	727	783	843	845	862	926	998
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-182	-118	-143	-206	-196	-198	-188	-60	-88	-163	-161
Capital Expenditures (CapEx)	18	17	26	31	71	83	88	132	89	61	58
Debt-free, Cash-free Net Working Capital (DFCFNWC)	73	77	81	79	53	61	62	126	117	97	96
Debt-free Net Working Capital (DFNWC)	256	195	225	285	249	259	250	186	206	260	257
Net Working Capital (NWC)	256	195	225	285	249	259	250	186	206	260	257
Net Nonoperating Expense (NNE)	0.20	-0.04	-0.76	-2.06	-3.56	-2.39	0.08	-0.38	-1.39	-4.75	5.37
Net Nonoperating Obligations (NNO)	-182	-118	-143	-206	-196	-198	-188	-60	-88	-163	-161
Total Depreciation and Amortization (D&A)	21	24	25	27	32	38	45	46	51	56	62
Debt-free, Cash-free Net Working Capital to Revenue	6.64%	6.44%	6.77%	6.49%	4.02%	4.58%	4.19%	7.51%	6.43%	5.16%	5.02%
Debt-free Net Working Capital to Revenue	23.14%	16.36%	18.68%	23.31%	19.03%	19.44%	17.01%	11.11%	11.29%	13.89%	13.48%
Net Working Capital to Revenue	23.14%	16.36%	18.68%	23.31%	19.03%	19.44%	17.01%	11.11%	11.29%	13.89%	13.48%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$3.72	$4.45	$4.21	$4.93	$5.48	$4.98	$5.17	$3.26	$4.04	$5.77	$6.08
Adjusted Weighted Average Basic Shares Outstanding	27.30M	27.34M	27.38M	27.40M	27.44M	27.45M	27.48M	27.45M	27.46M	27.44M	27.47M
Adjusted Diluted Earnings per Share	$3.72	$4.44	$4.20	$4.92	$5.46	$4.97	$5.16	$3.25	$4.04	$5.76	$6.07
Adjusted Weighted Average Diluted Shares Outstanding	27.33M	27.37M	27.44M	27.46M	27.54M	27.50M	27.52M	27.47M	27.48M	27.46M	27.49M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	27.36M	27.42M	27.45M	27.49M	27.49M	27.52M	27.53M	27.52M	27.53M	27.53M	27.53M
Normalized Net Operating Profit after Tax (NOPAT)	102	122	127	135	136	135	139	114	129	165	188
Normalized NOPAT Margin	9.22%	10.22%	10.56%	11.03%	10.38%	10.15%	9.47%	6.83%	7.09%	8.83%	9.83%
Pre Tax Income Margin	13.99%	15.50%	14.60%	14.24%	14.95%	13.42%	12.66%	6.70%	7.86%	10.98%	11.18%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	48.95%	156.49%	51.15%	47.69%	46.57%	55.22%	57.07%	96.85%	83.00%	61.74%	61.85%
Augmented Payout Ratio	49.51%	156.62%	51.90%	48.50%	51.49%	59.21%	63.07%	105.29%	91.27%	66.56%	66.63%

This table displays calculated financial ratios and metrics derived from Marzetti's official financial filings.

Metric	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	27,423,000.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	27,423,000.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	1.35
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	8.47%	1.79%	1.40%	-0.40%	1.08%	4.81%	-2.89%	4.99%	5.77%	1.70%	-0.98%
EBITDA Growth	18.25%	27.51%	17.39%	114.17%	1.43%	-3.49%	31.65%	23.83%	7.28%	1.77%	-2.41%
EBIT Growth	17.55%	29.68%	22.92%	251.92%	0.44%	-5.87%	40.50%	24.35%	5.02%	-1.11%	-6.79%
NOPAT Growth	14.55%	27.24%	12.26%	292.25%	-0.36%	16.33%	46.52%	-5.71%	6.61%	-0.75%	-9.73%
Net Income Growth	16.92%	28.80%	15.46%	279.97%	1.71%	-4.84%	45.06%	-6.60%	5.55%	20.59%	-9.89%
EPS Growth	16.91%	28.97%	15.73%	273.53%	1.89%	-4.81%	44.66%	-7.09%	5.56%	20.79%	-9.40%
Operating Cash Flow Growth	-29.98%	18.23%	73.71%	-18.33%	-44.15%	1.61%	-39.67%	158.60%	249.44%	-17.66%	53.97%
Free Cash Flow Firm Growth	190.12%	817.19%	1,213.13%	134.04%	5.65%	-6.12%	-221.36%	-197.39%	-49.26%	-93.37%	196.47%
Invested Capital Growth	0.90%	-1.22%	-5.34%	-1.48%	0.62%	0.30%	16.52%	9.80%	3.29%	7.01%	-5.20%
Revenue Q/Q Growth	1.52%	5.27%	-2.98%	-3.95%	3.03%	9.16%	-10.11%	3.84%	3.80%	4.96%	-12.47%
EBITDA Q/Q Growth	163.85%	13.88%	-36.80%	12.78%	24.96%	8.37%	-13.79%	6.08%	8.25%	21.14%	-29.85%
EBIT Q/Q Growth	362.94%	16.57%	-45.08%	18.75%	32.12%	9.24%	-18.02%	5.09%	11.59%	25.59%	-36.71%
NOPAT Q/Q Growth	412.46%	16.39%	-46.41%	22.71%	30.18%	35.88%	-32.50%	-21.03%	47.19%	26.50%	-38.61%
Net Income Q/Q Growth	379.50%	17.14%	-44.93%	22.85%	28.35%	9.60%	-16.06%	-20.90%	45.05%	25.22%	-37.28%
EPS Q/Q Growth	367.65%	17.61%	-44.92%	23.30%	27.56%	9.88%	-16.29%	-20.81%	44.92%	25.73%	-37.21%
Operating Cash Flow Q/Q Growth	-14.69%	197.37%	-28.30%	-55.09%	-41.66%	441.01%	-57.44%	92.50%	-21.17%	27.49%	-20.41%
Free Cash Flow Firm Q/Q Growth	89.56%	66.01%	15.43%	-35.57%	-14.43%	47.52%	-249.22%	48.30%	144.59%	-80.73%	2,071.47%
Invested Capital Q/Q Growth	4.04%	-3.79%	-3.41%	1.90%	6.25%	-4.10%	12.22%	-3.98%	-0.05%	-0.64%	-0.59%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	23.55%	25.00%	22.16%	21.56%	23.75%	26.07%	23.14%	22.32%	24.08%	26.50%	23.65%
EBITDA Margin	15.43%	16.69%	10.87%	12.77%	15.48%	15.37%	14.74%	15.06%	15.70%	18.13%	14.53%
Operating Margin	12.30%	13.53%	7.45%	9.21%	11.97%	14.86%	10.89%	8.19%	12.01%	14.52%	10.27%
EBIT Margin	12.49%	13.83%	7.83%	9.67%	12.41%	12.42%	11.32%	11.46%	12.32%	14.74%	10.66%
Profit (Net Income) Margin	9.52%	10.60%	6.01%	7.69%	9.58%	9.62%	8.98%	6.84%	9.56%	11.41%	8.17%
Tax Burden Percent	76.26%	76.64%	76.84%	79.50%	77.23%	77.48%	79.33%	80.30%	77.62%	77.39%	76.69%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	74.36%	100.00%	100.00%	100.00%
Effective Tax Rate	23.74%	23.36%	23.16%	20.50%	22.77%	22.52%	20.67%	19.70%	22.38%	22.61%	23.31%
Return on Invested Capital (ROIC)	21.75%	24.85%	13.95%	17.84%	21.49%	28.20%	20.13%	15.69%	21.92%	27.17%	18.01%
ROIC Less NNEP Spread (ROIC-NNEP)	20.81%	23.89%	12.87%	16.50%	20.00%	33.91%	19.06%	14.90%	21.17%	26.73%	17.23%
Return on Net Nonoperating Assets (RNNOA)	-1.65%	-3.07%	-1.78%	-2.32%	-2.29%	-6.05%	-2.89%	-2.52%	-3.42%	-5.37%	-2.90%
Return on Equity (ROE)	20.10%	21.78%	12.17%	15.51%	19.20%	22.15%	17.24%	13.18%	18.50%	21.80%	15.11%
Cash Return on Invested Capital (CROIC)	13.50%	17.42%	22.28%	21.53%	18.42%	20.58%	6.30%	12.26%	18.09%	15.00%	25.50%
Operating Return on Assets (OROA)	20.52%	22.58%	12.59%	15.61%	19.85%	19.75%	17.45%	17.63%	18.67%	22.32%	15.71%
Return on Assets (ROA)	15.65%	17.31%	9.67%	12.41%	15.33%	15.30%	13.84%	10.53%	14.49%	17.27%	12.05%
Return on Common Equity (ROCE)	20.10%	21.78%	12.17%	15.51%	19.20%	22.15%	17.24%	13.18%	18.50%	21.80%	15.11%
Return on Equity Simple (ROE_SIMPLE)	13.39%	14.22%	14.56%	0.00%	16.86%	16.01%	17.03%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	43	50	27	33	43	59	40	31	46	58	36
NOPAT Margin	9.38%	10.37%	5.73%	7.32%	9.25%	11.51%	8.64%	6.57%	9.32%	11.23%	7.88%
Net Nonoperating Expense Percent (NNEP)	0.95%	0.95%	1.08%	1.34%	1.49%	-5.72%	1.07%	0.79%	0.75%	0.44%	0.78%
Return On Investment Capital (ROIC_SIMPLE)	-	5.55%	-	-	-	5.98%	3.97%	3.13%	4.51%	5.63%	3.42%
Cost of Revenue to Revenue	76.45%	75.00%	77.84%	78.44%	76.25%	73.93%	76.86%	77.68%	75.92%	73.50%	76.35%
SG&A Expenses to Revenue	11.25%	11.47%	12.14%	11.75%	11.78%	11.21%	12.25%	13.06%	11.84%	11.66%	13.55%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	11.25%	11.47%	14.71%	12.35%	11.78%	11.21%	12.25%	17.07%	12.07%	11.98%	13.38%
Earnings before Interest and Taxes (EBIT)	58	67	37	44	58	63	52	54	61	76	48
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	71	81	51	58	72	78	67	72	77	94	66
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	5.07	4.94	6.23	5.62	5.14	4.87	4.84	4.77	4.67	4.38	3.63
Price to Tangible Book Value (P/TBV)	6.69	6.46	8.07	7.25	6.60	6.19	6.24	6.14	5.98	5.58	4.61
Price to Revenue (P/Rev)	2.40	2.41	3.04	2.78	2.59	2.51	2.56	2.49	2.46	2.32	1.96
Price to Earnings (P/E)	37.86	34.77	42.77	32.80	30.50	30.42	28.44	28.46	28.01	25.12	21.57
Dividend Yield	2.10%	2.11%	1.69%	1.88%	2.04%	2.11%	2.11%	2.17%	2.20%	2.34%	2.82%
Earnings Yield	2.64%	2.88%	2.34%	3.05%	3.28%	3.29%	3.52%	3.51%	3.57%	3.98%	4.64%
Enterprise Value to Invested Capital (EV/IC)	5.44	5.63	7.38	6.61	5.83	5.88	5.39	5.50	5.47	5.19	4.33
Enterprise Value to Revenue (EV/Rev)	2.36	2.33	2.95	2.69	2.52	2.40	2.49	2.41	2.36	2.22	1.84
Enterprise Value to EBITDA (EV/EBITDA)	21.32	19.54	23.95	19.27	18.01	17.60	17.04	15.89	15.52	14.56	12.12
Enterprise Value to EBIT (EV/EBIT)	28.84	26.04	31.71	24.52	22.96	22.64	21.69	20.23	19.86	18.82	15.82
Enterprise Value to NOPAT (EV/NOPAT)	37.96	34.53	42.76	32.75	30.74	28.22	26.92	26.64	26.06	24.67	20.89
Enterprise Value to Operating Cash Flow (EV/OCF)	20.79	19.19	21.30	20.03	20.04	19.24	22.66	17.60	14.71	14.78	11.28
Enterprise Value to Free Cash Flow (EV/FCFF)	40.48	32.09	32.23	30.47	31.77	28.62	92.16	46.94	30.71	35.81	16.51
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.08	-0.13	-0.14	-0.14	-0.11	-0.18	-0.15	-0.17	-0.16	-0.20	-0.17
Leverage Ratio	1.30	1.28	1.30	1.30	1.29	1.27	1.28	1.29	1.30	1.28	1.29
Compound Leverage Factor	1.30	1.28	1.30	1.30	1.29	1.27	1.28	0.96	1.30	1.28	1.29
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	14.56	15.16	16.98	14.84	14.55	14.83	13.95	14.02	12.52	12.86	10.88
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.31	2.48	2.32	2.41	2.61	2.88	2.36	2.38	2.48	2.72	2.58
Quick Ratio	1.16	1.43	1.41	1.41	1.37	1.81	1.24	1.38	1.41	1.69	1.59
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	36	60	69	45	38	56	-84	-43	19	3.73	81
Operating Cash Flow to CapEx	194.29%	563.19%	512.29%	394.25%	112.80%	976.13%	304.26%	617.28%	444.81%	501.45%	331.52%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.64	1.63	1.61	1.61	1.60	1.59	1.54	1.54	1.52	1.51	1.47
Accounts Receivable Turnover	14.50	16.44	16.07	17.78	16.94	19.06	18.01	19.95	19.05	19.17	18.91
Inventory Turnover	8.50	9.74	9.15	8.68	7.77	8.94	8.17	8.49	8.01	8.96	8.03
Fixed Asset Turnover	3.88	3.84	3.87	3.90	3.87	3.92	3.69	3.77	3.79	3.82	3.58
Accounts Payable Turnover	11.42	12.29	11.16	12.49	12.57	13.94	11.92	12.28	12.03	12.96	11.51
Days Sales Outstanding (DSO)	25.17	22.20	22.71	20.53	21.55	19.15	20.27	18.29	19.16	19.04	19.30
Days Inventory Outstanding (DIO)	42.96	37.47	39.87	42.03	47.00	40.83	44.66	43.01	45.58	40.76	45.46
Days Payable Outstanding (DPO)	31.96	29.69	32.69	29.23	29.05	26.18	30.63	29.73	30.33	28.17	31.72
Cash Conversion Cycle (CCC)	36.17	29.98	29.89	33.33	39.50	33.79	34.29	31.58	34.41	31.64	33.04
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	805	774	748	762	810	777	872	837	837	831	826
Invested Capital Turnover	2.32	2.40	2.44	2.44	2.32	2.45	2.33	2.39	2.35	2.42	2.29
Increase / (Decrease) in Invested Capital	7.17	-9.59	-42	-11	4.97	2.32	124	75	27	54	-45
Enterprise Value (EV)	4,380	4,357	5,522	5,038	4,725	4,570	4,701	4,602	4,575	4,318	3,575
Market Capitalization	4,454	4,490	5,687	5,202	4,860	4,773	4,825	4,763	4,758	4,519	3,793
Book Value per Share	$31.92	$33.01	$33.17	$33.63	$34.33	$35.55	$36.13	$36.22	$37.00	$37.58	$38.10
Tangible Book Value per Share	$24.18	$25.27	$25.60	$26.06	$26.76	$27.99	$28.03	$28.14	$28.91	$29.47	$29.98
Total Capital	879	908	913	926	945	980	996	998	1,019	1,033	1,045
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-74	-134	-165	-163	-135	-203	-125	-161	-182	-202	-218
Capital Expenditures (CapEx)	18	19	15	8.65	18	11	15	14	16	18	21
Debt-free, Cash-free Net Working Capital (DFCFNWC)	145	108	86	97	144	111	129	96	116	109	97
Debt-free Net Working Capital (DFNWC)	219	242	251	260	279	314	253	257	298	311	315
Net Working Capital (NWC)	219	242	251	260	279	314	253	257	298	311	315
Net Nonoperating Expense (NNE)	-0.65	-1.09	-1.34	-1.69	-1.56	9.63	-1.55	-1.28	-1.19	-0.90	-1.34
Net Nonoperating Obligations (NNO)	-74	-134	-165	-163	-135	-203	-125	-161	-182	-202	-218
Total Depreciation and Amortization (D&A)	14	14	14	14	14	15	16	17	17	18	18
Debt-free, Cash-free Net Working Capital to Revenue	7.82%	5.79%	4.60%	5.16%	7.69%	5.82%	6.82%	5.02%	5.98%	5.61%	4.98%
Debt-free Net Working Capital to Revenue	11.79%	12.96%	13.39%	13.89%	14.89%	16.51%	13.43%	13.48%	15.39%	15.98%	16.24%
Net Working Capital to Revenue	11.79%	12.96%	13.39%	13.89%	14.89%	16.51%	13.43%	13.48%	15.39%	15.98%	16.24%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.60	$1.87	$1.03	$1.27	$1.62	$1.78	$1.49	$1.19	$1.71	$2.15	$1.35
Adjusted Weighted Average Basic Shares Outstanding	27.45M	27.43M	27.44M	27.44M	27.46M	27.48M	27.48M	27.47M	27.46M	27.40M	27.36M
Adjusted Diluted Earnings per Share	$1.59	$1.87	$1.03	$1.27	$1.62	$1.78	$1.49	$1.18	$1.71	$2.15	$1.35
Adjusted Weighted Average Diluted Shares Outstanding	27.47M	27.44M	27.45M	27.46M	27.48M	27.50M	27.50M	27.49M	27.49M	27.42M	27.38M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	27.52M	27.52M	27.53M	27.53M	27.57M	27.57M	27.57M	27.53M	27.49M	27.42M	27.42M
Normalized Net Operating Profit after Tax (NOPAT)	43	50	36	33	43	59	40	31	47	59	35
Normalized NOPAT Margin	9.38%	10.37%	7.71%	7.32%	9.25%	11.51%	8.64%	6.57%	9.50%	11.48%	7.74%
Pre Tax Income Margin	12.49%	13.83%	7.83%	9.67%	12.41%	12.42%	11.32%	8.52%	12.32%	14.74%	10.66%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	79.69%	73.63%	72.61%	61.74%	62.35%	64.26%	60.20%	61.85%	61.80%	59.08%	61.19%
Augmented Payout Ratio	93.09%	85.77%	78.35%	66.56%	63.87%	65.79%	61.11%	66.63%	66.33%	74.49%	76.93%

Financials Breakdown Chart

Key Financial Trends

Here are the key trends in Lancaster Colony Corp (MZTI) based on quarterly statements over the last four years. The focus is on cash flow, earnings, and balance-sheet strength to help retail investors gauge profitability, liquidity, and financial flexibility.

Net income growth: Net income attributable to common shareholders rose to about $59.1 million in Q2 2026 from about $49.0 million in Q2 2025 (roughly +21%), signaling improving profitability.
Robust free cash flow: In Q2 2026, net cash from continuing operating activities was about $88.6 million and capital expenditures were about $17.7 million, yielding roughly $70.9 million of free cash flow for the quarter.
Solid liquidity position: Cash & equivalents were about $201.6 million at 6/30/2026; total current assets around $491.4 million vs. current liabilities of about $180.7 million, giving a healthy current ratio of roughly 2.7x.
Conservative leverage: Total liabilities were about $296.0 million vs. total equity of roughly $1.03 billion (debt-to-equity around 0.29x), indicating a manageable balance sheet load.
Revenue trend supports growth: Revenue has trended higher across recent quarters (Q2 2026 operating revenue about $518.0 million vs. Q3 2025 around $457.8 million and earlier quarters mid-$400s to mid-$500s), suggesting top-line expansion.
Stable gross margins with improvement: Total gross profit in Q2 2026 was about $137.3 million on $517.9 million in revenue (roughly 26.5% gross margin), improving versus earlier periods where margins were in the lower 20s—indicating better cost control or product mix.
Dividend policy and per-share dividends: Quarterly cash dividends per share have been steady in the range of $0.95–$1.00 (e.g., $1.00 in Q2 2026 and $0.95 in several other recent quarters), providing ongoing income to shareholders without dramatic changes.
Capex levels are moderate and steady: Capital expenditures run in the $14–$18 million per quarter range (e.g., Q2 2026 capex about $17.7 million; Q1 2026 about $15.6 million; Q4 2025 about $14.3 million), indicating ongoing investment without drastic swings.
Financing outflows constrain cash: Net cash from financing activities has been negative in multiple quarters (e.g., Q2 2026 around −$48.2 million), driven by share repurchases and dividends, which reduces cash on hand despite strong operating cash flow.
Quarterly operating cash flow can be volatile: Cash from continuing operations declined in some quarters (e.g., Q2 2026 CFO ≈ $88.6 million vs. Q2 2025 CFO ≈ $107.6 million), indicating quarterly variability in cash generation even as the longer-term trend remains solid.

05/17/26 01:08 PM ETAI Generated. May Contain Errors.

Marzetti Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Marzetti's financial year ends in June. Their financial year 2025 ended on June 30, 2025.

Marzetti's net income appears to be on an upward trend, with a most recent value of $167.35 million in 2025, rising from $101.69 million in 2015. The previous period was $158.61 million in 2024. See Marzetti's forecast for analyst expectations on what's next for the company.

Marzetti's total operating income in 2025 was $220.32 million, based on the following breakdown:

Total Gross Profit: $455.65 million
Total Operating Expenses: $249.30 million

Over the last 10 years, Marzetti's total revenue changed from $1.10 billion in 2015 to $1.91 billion in 2025, a change of 72.8%.

Marzetti's total liabilities were at $276.23 million at the end of 2025, a 1.8% decrease from 2024, and a 127.8% increase since 2015.

In the past 10 years, Marzetti's cash and equivalents has ranged from $60.28 million in 2022 to $205.75 million in 2018, and is currently $161.48 million as of their latest financial filing in 2025.

Over the last 10 years, Marzetti's book value per share changed from 21.23 in 2015 to 36.22 in 2025, a change of 70.6%.

Related Companies

Financial statements for NASDAQ:MZTI last updated on 5/8/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Marzetti (MZTI) Financials

Financials Breakdown Chart

Key Financial Trends

Marzetti Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Marzetti (MZTI) Financials

Annual Income Statements for Marzetti

Quarterly Income Statements for Marzetti

Annual Cash Flow Statements for Marzetti

Quarterly Cash Flow Statements for Marzetti

Annual Balance Sheets for Marzetti

Quarterly Balance Sheets for Marzetti

Annual Metrics And Ratios for Marzetti

Quarterly Metrics And Ratios for Marzetti

Financials Breakdown Chart

Key Financial Trends

Marzetti Financials - Frequently Asked Questions

When does Marzetti's fiscal year end?

How has Marzetti's net income changed over the last 10 years?

What is Marzetti's operating income?

How has Marzetti's revenue changed over the last 10 years?

How much debt does Marzetti have?

How much cash does Marzetti have?

How has Marzetti's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools